Found: 21
Select item for more details and to access through your institution.
Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 658, doi. 10.1038/bmt.2014.320
- By:
- Publication type:
- Article
Alternative donor transplant of benign primary hematologic disorders.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 619, doi. 10.1038/bmt.2015.1
- By:
- Publication type:
- Article
Outcomes after autologous SCT in lymphoma patients grouped by weight.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 652, doi. 10.1038/bmt.2014.327
- By:
- Publication type:
- Article
Related hematopoietic cell donor care: is there a role for unrelated donor registries?
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 637, doi. 10.1038/bmt.2015.15
- By:
- Publication type:
- Article
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 673, doi. 10.1038/bmt.2014.322
- By:
- Publication type:
- Article
Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 706, doi. 10.1038/bmt.2014.325
- By:
- Publication type:
- Article
Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 746, doi. 10.1038/bmt.2015.8
- By:
- Publication type:
- Article
Once-daily i.v. BU-based conditioning regimen before allogeneic hematopoietic SCT: a study of influence of GST gene polymorphisms on BU pharmacokinetics and clinical outcomes in Chinese patients.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 696, doi. 10.1038/bmt.2015.14
- By:
- Publication type:
- Article
Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 685, doi. 10.1038/bmt.2015.20
- By:
- Publication type:
- Article
Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 715, doi. 10.1038/bmt.2015.2
- By:
- Publication type:
- Article
A multigene array for measurable residual disease detection in AML patients undergoing SCT.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 642, doi. 10.1038/bmt.2014.326
- By:
- Publication type:
- Article
A time to stop, a time to start: high-dose chemotherapy in overweight and obese patients.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 617, doi. 10.1038/bmt.2015.26
- By:
- Publication type:
- Article
Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 663, doi. 10.1038/bmt.2015.13
- By:
- Publication type:
- Article
Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 727, doi. 10.1038/bmt.2015.17
- By:
- Publication type:
- Article
5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 690, doi. 10.1038/bmt.2015.10
- By:
- Publication type:
- Article
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 628, doi. 10.1038/bmt.2014.323
- By:
- Publication type:
- Article
Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 743, doi. 10.1038/bmt.2015.3
- By:
- Publication type:
- Article
Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 734, doi. 10.1038/bmt.2015.19
- By:
- Publication type:
- Article
Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 679, doi. 10.1038/bmt.2014.328
- By:
- Publication type:
- Article
Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 721, doi. 10.1038/bmt.2015.4
- By:
- Publication type:
- Article
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 668, doi. 10.1038/bmt.2015.21
- By:
- Publication type:
- Article